We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

601233:SSETongkun Group Co., Ltd. Class A Analysis

Data as of 2026-06-15 - not real-time

CN¥23.47

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Tongkun Group is trading around CNY 23.5, well below its DCF‑derived fair value of roughly CNY 50, implying a substantial upside potential. The stock’s 20‑day and 50‑day SMAs sit just above the current price, while the MACD histogram remains positive and the RSI is in the mid‑60s, indicating bullish momentum without overbought pressure.
On the fundamentals side, revenue is expanding at a healthy 20% year‑over‑year, but gross and operating margins linger around 5‑6%, and free cash flow is negative despite a strong cash balance. The company carries a very high debt‑to‑equity ratio of over 160, which raises concerns, yet the dividend payout is modest at 7% of earnings, supporting dividend sustainability. The stock exhibits high 30‑day volatility (≈60%) but a low computed beta, suggesting price swings are more company‑specific than market‑driven. Overall, the valuation gap and growth narrative are compelling, but the debt load and thin profitability temper enthusiasm.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD and rising volume support near‑term stability
  • Price is approaching a technical resistance around CNY 24.5
  • RSI below overbought levels leaves room for modest upside

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF valuation suggests >100% upside
  • Revenue growth of 20% outpaces many peers
  • Low dividend payout ratio provides cushion for earnings retention

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • High debt‑to‑equity ratio and negative free cash flow pose structural risk
  • Cyclical consumer textile exposure may limit sustained growth
  • Dividend sustainability and modest payout support shareholder returns

Key Metrics & Analysis

Financial Health

Revenue Growth20.30%
Profit Margin3.39%
P/E Ratio16.8
ROE8.53%
ROA1.16%
Debt/Equity160.01
P/B Ratio1.4
Op. Cash FlowCN¥7.9B
Free Cash FlowCN¥-4580726784

Technical Analysis

TrendNeutral
RSI64.0
SupportCN¥18.36
ResistanceCN¥24.53
MA 20CN¥20.37
MA 50CN¥20.45
MA 200CN¥17.72
MACDBullish
VolumeIncreasing
Fear & Greed Index91.63

Valuation

Fair ValueCN¥50.34
GradeUndervalued
TypeBlend
Dividend Yield0.45%

Risk Assessment

Beta0.33
Volatility60.30%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.